The DAK-Gesundheit is seeking suppliers to enter into a non-exclusive discount agreement for the pharmaceutical substances Dolutegravir and Rilpivirine, classified under ATC J05AR21. This agreement will be effective from July 1, 2025, to June 30, 2027. The contract is part of a framework that allows
322 days left to bid. Opened 1 years ago, deadline 5 May 2027.
This contract opportunity involves the collection of used paper and the destruction of documents and data carriers across Germany. Suppliers are invited to provide services that include the secure destruction of paper, cardboard, and other materials. Detailed specifications of the required services
DAK Health is seeking external support for the development of innovative IT solutions in response to the ongoing digital transformation in the German healthcare sector. This need arises from new legal requirements and the challenges posed by a volatile political environment and a shortage of skilled
This contract involves a non-exclusive discount agreement for the pharmaceutical substances Adapalene and Benzoyl Peroxide, classified under ATC code D10AD23. The agreement is established under Section 130a, Paragraph 8 of the German Social Code (SGB V), allowing health insurance funds and pharmaceu
DAK Health is seeking external support for the development of innovative IT solutions in response to the ongoing digitalization of the German healthcare system and related legal requirements. Due to the volatile political environment and the structural shortage of skilled IT professionals, DAK Healt
North West London Pathology seeks a managed service partner to deliver integrated laboratory premises, equipment, and facilities management through a volume-based pricing model with risk and reward sharing over 14 years.
Competitive tender to deliver community-based minor surgery services in Newham, including skin procedures, joint injections, and cryotherapy, with a 2-year initial contract worth up to £1.3 million.
Qualified laboratories are sought to deliver pharmacogenomic testing for 4,854 patients across Northern Ireland and Ireland to optimize medicines prescribing in primary care.
Market engagement survey for extracorporeal photopheresis systems and consumables suppliers - submit questionnaire by 17 July 2026 via eTendersNI.
